Adverts

Open Access Articles- Top Results for Ascrinvacumab

Ascrinvacumab

</th></tr>
Ascrinvacumab?
Monoclonal antibody
Source Human
Target activin receptor-like kinase 1
Clinical data
Identifiers
1463459-96-2
None
Chemical data
Formula C6396H9850N1694O2012S44
144.1 kDa

Ascrinvacumab is a monoclonal antibody designed for the treatment of cancer.[1]

This drug was developed by Pfizer Inc.

References

  1. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Ascrinvacumab, American Medical Association.

Lua error in package.lua at line 80: module 'Module:Buffer' not found.